Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents
1Schwerpunkt gynäkologische Onkologie, Frauenklinik, Klinikum der Stadt Wolfsburg, Wolfsburg
2 Frauenklinik, Krankenhaus Altona, Hamburg
3Institut für Pathologie, MHH, Hannover
4Clinical Cancer Registry, MHH, Hannover (Germany)
5Deptartment of Pathology, Vrije Universiteit Amsterdam, Amsterdam (The Netherlands)
6Institut für experimentelle Virologie, Universität Tübingen, Tübingen (Germany)
*Corresponding Author(s): Petry KU E-mail: gyn@klinikum.wolfsburg.de
Cancer of the uterine cervix is almost exclusively associated with human papillomavirus (HPV). Carcinogenesis is slow, the minimal time from initial HPV infection to invasive carcinoma seems to be less than ten years. In order to identify rapid onset cervical cancer. we carried out a retrospective re-analysis of an extended cohort of patients with invasive cervical cancer, and reviewed cases identified within the cancer registry of Lower Saxony or using Medline or ISI data. No instances of a rapid-onset cancer or true HPV-DNA negative cancer were found among our hospital cohort of 178 women with primary cancer of the uterine cervix. Registry data identified four out of 5,878 patients who were diagnosed with primary cervical cancer at 14 to 20 years of age. The), were classified as clear-cell and endometriod adenocarcinoma and tested persistently negative for high-risk HPV-DNA. Fourteen more cases of cervical cancer in virgins and very young women were identified by a Medline search, mostly with unknown histologic type or rare subtypes of adenocarcinoma. In conclusion, rare adenocarcinoma of the uterine cervix may represent an entity unrelated to HPV, thus explaining instances of rapid onset cervical cancer.
HPV-negative; Cervical cancer rapid onset
Liebrich C,Brummer O,Von Wasielewski R,Wegener G,Meijer C ,Iftner T,Petry KU. Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents. European Journal of Gynaecological Oncology. 2009. 30(1);45-48.
[1] Moscicki A.B., Shiboski S., Broering J., Powell K., Clayton L., JayN. et al.: The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr, 1998, 132, 277.
[2] Nobbenhuis M.A., Walboomers J.M., Helmerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K. et al.: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet, 1999, 354, 20.
[3] Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell.D.M. , Rush B.B. et al.: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst., 1993, 85, 958.
[4] Munoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., GiliM. et al.: The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer, 1992, 52, 743.
[5] Walboomers J.M., de Roda Husman A.M., Snijders P.J., Stel H.V., Risse E.K., Helmerhorst T.J. et al.: Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J. Clin. Pathol. , 1995, 48, 728.
[6] Hildesheim A., Hadjimichael O., Schwartz P.E., Wheeler C.M., Barnes W., Lowell D.M. et al.: Risk factors for rapid-onset cervical cancer. Am. J. Obstet. Gynecol. , 1999, 180 (3 Pt 1), 571.
[7] Bohmer G., van den Brule A.J., Brummer O., Meijer C.L., PetryK.U.: No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients. Am. J. Obstet. Gynecol. , 2003, 189, 118.
[8] Iftner A., Klug S.J., Garbe C., Blum A., Stancu A., Wilczynski S.P. et al.: The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res., 2003, 63, 7515.
[9] Seki H., Takada T., Sodemoto T., Hoshino H., Saitoh K., UekusaT. : A young woman with clear cell adenocarcinoma of the uterine cervix. Int. J. Clin. Oncol. , 2003, 8, 399.
[10] Hanselaar A.G., Van Leusen N.D., De Wilde P.C., Vooijs G.P.: Clear cell adenocarcinoma of the vagina and cervix. A report of the Central Netherlands Registry with emphasis on early detection and prognosis. Cancer, 1991, 67, 1971.
[11] Pirog E.C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.G. et al.: Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am. J Pathol. , 2000, 157, 1055.
[12] Waggoner S.E., Anderson S.M., Van Eyck S., Fuller J., Luce M.C., Herbst A.L.: Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet. Gynecol. , 1994, 84, 404.
[13] Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S. et al.: Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer,2006, 119, 1095
[14] Bowing H.H., McCullough J.A.L.: Carcinoma of the cervix uteri in childhood and adolescence. Am. J. Roentgen, 1941, 45, 819.
[15] Shaw W.F: Carcinoma of the cervix in a girl fifteen years of age.J. Obstet. Gynecol. Br. Emp., 1941, 48, 239.
[16] Stadler G.C.: Cervix carcinoma in a 17 year old virgin. Geburtshilfe Frauenheilk, 1966, 26, 257.
[17] Andrews FJ. , Linehan J.J., Melcher D.H.: Cervical cancer in younger women. Lancet, 1978, 2, 776.
[18] Dekel A., van Iddekinge B., Leiman G.: Invasive squamous carcinoma of the cervix in a 15-year-old girl. A case report and review of the literature. S. Afr. Med. J., 1982, 61, 628.
[19] Palit A., McDowell H., Carty H., Rintala R., Kokai G.: Endometroid adenocarcinoma of the cervix in a 9-year-old girl. Br. J. Radiol. , 1998, 71, 1093.
[20] Graf A.-H. , Pickel H., Hacker G.W., Staudach A.: Invasive adenocarcinoma of the uterine cervix in a 17-year-old girl- a casereport. Geburtsh Frauenheilk, 1998, 58, 620.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top